Mercer Global Advisors
ICCC icon

Mercer Global Advisors’s ImmuCell ICCC Stock Holding History

Mercer Global Advisors’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Buy
+12,000
New +$106K ﹤0.01% 3385
2021
Q3 		– Sell
-11,202
Closed -$106K – 1781
2021
Q2 		$106K Hold
11,202
– – ﹤0.01% 1617
2021
Q1 		$108K Hold
11,202
– – ﹤0.01% 1549
2020
Q4 		$67K Hold
11,202
– – ﹤0.01% 1311
2020
Q3 		$61K Buy
+11,202
New +$62.1K ﹤0.01% 1197

Other funds holding ICCC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
S
Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Mercer Global Advisors's ICCC Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in ImmuCell (ICCC) in Q2 2026: 12,000 shares worth $121K. The stake represents ﹤0.01% of the portfolio and ranks #3385 among its holdings. This is a return to the name: Mercer Global Advisors previously reported a position in ICCC as recently as Q2 2021.

Mercer Global Advisors first reported a position in ICCC in Q3 2020 and has held it in 5 quarters since. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

  • Mercer Global Advisors held 12,000 shares of ImmuCell worth $121K as of Q2 2026.
  • ImmuCell was a new Mercer Global Advisors position in Q2 2026.
  • ImmuCell made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3385 holding.
  • Mercer Global Advisors first reported a position in ImmuCell in Q3 2020 and has held it in 5 quarters since.
  • 31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.